Skip to main content
Caplight Logo









TenAces Biosciences

TenAces Biosciences

Private
IsraelHealthcare & Life Scienceshttp://tenaces.bio

Last Round

Seed

Jan 30, 2024

Company Overview

TenAces Biosciences is a biotechnology company that leverages machine learning and data-centric approaches to discover and develop molecular glue therapeutics for targeted protein degradation.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

molecular gluetargeted protein degradationTPDAI drug discoveryundruggable targetscomputational biologyrational drug designvirtual screeningprotein-ligand interactionbiotech startupin silico drug discoveryAI-first biotechsmall molecule therapeuticsdrug discovery platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TenAces Biosciences Comparables

Compare TenAces Biosciences with similar companies based on industry and business-model similarity.

TenAces Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ternary Therapeutics
95%
GluBio Therapeutics
86%
Degron Therapeutics
84%

TenAces Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 30, 2024

TenAces Biosciences Investors

Notable investors and investment history

TenAces Biosciences investors
InvestorRounds
Israel Biotech FundSeed
Amiti VenturesSeed
PfizerSeed
AION LabsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 30, 2024

    Seed round included investors Pfizer, Amiti Ventures, and Israel Biotech Fund.

TenAces Biosciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TenAces Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TenAces Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Year Founded2024
Last FundingJan 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?